Citadel Advisors - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V959. A total of 3 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2016$153,000
-13.6%
11,800
+6.3%
0.00%
Q1 2016$177,000
-86.5%
11,100
-75.8%
0.00%
-100.0%
Q4 2015$1,311,000
+113.2%
45,800
+112.0%
0.00%0.0%
Q3 2015$615,000
-67.8%
21,600
-59.3%
0.00%
-50.0%
Q2 2015$1,907,000
+73.5%
53,100
+181.0%
0.00%
+100.0%
Q1 2015$1,099,000
+103.5%
18,900
+47.7%
0.00%0.0%
Q4 2014$540,000
+4.7%
12,800
-3.8%
0.00%0.0%
Q3 2014$516,000
+218.5%
13,300
+155.8%
0.00%
Q2 2014$162,0005,2000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
Citadel Advisors 12,800$540,0000.00%
GROUP ONE TRADING, L.P. 300$13,0000.00%
SIMPLEX TRADING, LLC 1$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders